Open AccessUpdated Guidelines for Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
Author(s) -
John D. Bartlett
Publication year - 2004
Publication title -
infectious diseases in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 21
eISSN - 1536-9943
pISSN - 1056-9103
DOI - 10.1097/01.idc.0000130888.27859.52
Subject(s) - rifabutin , medicine , reverse transcriptase , virology , pharmacology , protease , reverse transcriptase inhibitor , ritonavir , human immunodeficiency virus (hiv) , enzyme , biology , sida , viral load , viral disease , polymerase chain reaction , antiretroviral therapy , biochemistry , gene , helicobacter pylori , clarithromycin